Loading stock data…
Loading stock data…
US$0.01
Get one email when EVFM crosses your level. Checked every 15 minutes during market hours.
▲ +0.00 (2.67%)up today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
45.2
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
0.00
Bearish momentumMACD below its signal line (0.00).
50-day average
0.01
Price belowShort-term trend reference.
200-day average
0.01
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Evofem Biosciences Inc. is a commercial-stage biopharmaceutical company specializing in the development and commercialization of innovative products targeting unmet needs in women's sexual and reproductive health. The company’s primary offering is Phexxi, an FDA-approved, hormone-free, on-demand prescription contraceptive vaginal gel designed to prevent pregnancy by reducing sperm motility and inhibiting fertilization. Phexxi provides women with a non-hormonal option for birth control and is dis…
www.evofem.com0 strong buy · 0 buy · 3 hold · 1 sell · 2 strong sell (6 analysts, 2025-03-01)
0 strong buy · 0 buy · 3 hold · 1 sell · 2 strong sell (6 analysts, 2025-02-01)
0 strong buy · 0 buy · 3 hold · 1 sell · 2 strong sell (6 analysts, 2025-01-01)
0 strong buy · 0 buy · 3 hold · 1 sell · 2 strong sell (6 analysts, 2024-12-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2025-12-03 | 0.27 | 0.45 | ✓ Beat |
| 2024-03-27 | -0.61 | -0.44 | ✓ Beat |
| 2023-04-26 | -26.25 | -38.75 | ✗ Miss |
| 2023-01-05 | -0.25 | -0.04 | ✓ Beat |
| 2022-08-11 | -0.98 | -4.57 | ✗ Miss |
Companies in the same industry, via Finnhub